Once the inflammatory, symptom-remitting stage of the disease has become progressive, standardization of symptomatology among individuals occurs. Three of them are referred to as the ABC s Avonex, Betaseron and Copaxone. Studies have shown that they lessen the frequency and severity of MS attacks and slow progression. Currently, physicians are prescribing the ABCs for secondary progressive MS as long as there is still inflammatory activity. The primary goal today is zero tolerance of inflammation.
Medications are also available to treat individual motor and mood symptoms as they occur.
IV Solu-Medrol is the standard treatment to hasten recovery from exacerbations. Some people with MS take part in physical therapy or yoga to help maintain flexibility, coordination and strength. A balanced diet and being sensitive to fatigue can help a person keep a maximum energy level. Various compensatory techniques are available to help memory and concentration problems. The consensus in the medical community today is that Multiple Sclerosis is an autoimmune disease in someone who is genetically vulnerable to immune system damage from cumulative virus exposure in childhood.